Case Report

Published on 14 Mar 2022

Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report

in Cancer Immunity and Immunotherapy

Jing Wu
Zheng Wang
Jing Li
Xue-Hui Peng
Yi-Chen Tang
Xiao-Bing Huang
Yong-Gang He

Frontiers in Oncology

doi 10.3389/fonc.2022.818626

2,193 views
3 citations

Editorial

Published on 10 Mar 2022

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies

in Cancer Immunity and Immunotherapy

Giulia Pasello
Jordi Remon
Emanuela Felley-Bosco

Frontiers in Oncology

doi 10.3389/fonc.2022.871544

1,244 views

Original Research

Published on 10 Mar 2022

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma

in Cancer Immunity and Immunotherapy

Songshan Feng
Zhijie Xu
Jinwu Peng
Mingyu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.847821

2,206 views
4 citations

Original Research

Published on 10 Mar 2022

Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis

in Cancer Immunity and Immunotherapy

Vasiliki Economopoulos
Maria Pannell
Vanessa A. Johanssen
Helen Scott
Kleopatra E. Andreou
James R. Larkin
Nicola R. Sibson

Frontiers in Oncology

doi 10.3389/fonc.2022.850656

2,885 views
2 citations

Case Report

Published on 09 Mar 2022

Case Report: Management of Recurrent Ovarian Squamous Cell Carcinoma With PD-1 Inhibitor

in Cancer Immunity and Immunotherapy

Xiao-chen Song
Yong-xue Wang
Mei Yu
Dong-yan Cao
Jia-xin Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.789228

2,084 views
6 citations

Original Research

Published on 08 Mar 2022

Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model

in Cancer Immunity and Immunotherapy

Gianluca Selvaggio
Silvia Parolo
Pranami Bora
Lorena Leonardelli
John Harrold
Khamir Mehta
Dan A. Rock
Luca Marchetti

Frontiers in Oncology

doi 10.3389/fonc.2022.818641

5,103 views
6 citations

Case Report

Published on 07 Mar 2022

Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma

in Cancer Immunity and Immunotherapy

Chun-Hong Hu
Shenghao Shi
Wen Dong
Lizhi Xiao
Hongjing Zang
Fang Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.799549

3,015 views
11 citations

Case Report

Published on 07 Mar 2022

Successful Treatment of a Patient With Multiple-Line Relapsed Extensive-Stage Small-Cell Lung Cancer Receiving Penpulimab Combined With Anlotinib: A Case Report

in Cancer Immunity and Immunotherapy

Zibo Zhang
Yujun Li
Yan Dong
Jia Li
Bin Zhang
Chunxia Zhang
Xiaonan Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.846597

6,275 views
8 citations

Original Research

Published on 04 Mar 2022

Benefits of Targeted Molecular Therapy to Immune Infiltration and Immune-Related Genes Predicting Signature in Breast Cancer

in Cancer Immunity and Immunotherapy

Fahai Chen
Jianmin Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.824166

2,387 views
2 citations

Review

Published on 03 Mar 2022

Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

in Cancer Immunity and Immunotherapy

Agnese Barnabei
Lidia Strigari
Andrea Corsello
Rosa Maria Paragliola
Luca Falzone
Roberto Salvatori
Salvatore Maria Corsello
Francesco Torino

Frontiers in Oncology

doi 10.3389/fonc.2022.798517

4,105 views
10 citations

Case Report

Published on 03 Mar 2022

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

in Cancer Immunity and Immunotherapy

Weiran Xu
Kai Wang
Wenguang Gu
Xinxin Nie
Hao Zhang
Chuanhao Tang
Li Lin
Jun Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.809068

2,858 views
10 citations

Original Research

Published on 03 Mar 2022

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

in Cancer Immunity and Immunotherapy

Zheng Zhu
Kun-Yu Teng
Jian Zhou
Yunyun Xu
Lifeng Zhang
Hua Zhao
Xueguang Zhang
Lei Tian
Zhiyao Li
Ting Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.814312

4,846 views
6 citations

Case Report

Published on 01 Mar 2022

Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Nanxiang Chen
Wei Ba
Dawei Zhao
Lei Sheng
Xinxin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.816903

2,885 views
4 citations

Case Report

Published on 28 Feb 2022

Case Report: Opportunities and Challenges of Immunotherapy in Heavily-Treated EGFR-Mutant Advanced Squamous Cell Lung Carcinoma After Progression on EGFR-TKIs and Chemotherapy

in Cancer Immunity and Immunotherapy

Wei Jin
Xin Wang
Jie Wang
Lin Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.820408

2,203 views
1 citation

Original Research

Published on 28 Feb 2022

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

in Cancer Immunity and Immunotherapy

Michael Berszin
Ioannis Michaelides
Julia Siemert
Louisa Röhl
Jana Wellhausen
Theresa Wald
Christopher Bohr
Julian Künzel
Tanja Gradistanac
Andreas Dietz

Frontiers in Oncology

doi 10.3389/fonc.2022.795277

3,291 views
5 citations

Systematic Review

Published on 25 Feb 2022

Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Yao Jin
Jiayan Wei
Yiming Weng
Jia Feng
Zexi Xu
Peiwei Wang
Xue Cui
Xinyi Chen
Jinsong Wang
Min Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.732814

4,251 views
5 citations

Navigation group

Articles

Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma

Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis

Case Report: Management of Recurrent Ovarian Squamous Cell Carcinoma With PD-1 Inhibitor

Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model

Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma

Successful Treatment of a Patient With Multiple-Line Relapsed Extensive-Stage Small-Cell Lung Cancer Receiving Penpulimab Combined With Anlotinib: A Case Report

Benefits of Targeted Molecular Therapy to Immune Infiltration and Immune-Related Genes Predicting Signature in Breast Cancer

Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review

Case Report: Opportunities and Challenges of Immunotherapy in Heavily-Treated EGFR-Mutant Advanced Squamous Cell Lung Carcinoma After Progression on EGFR-TKIs and Chemotherapy

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis